Watch HQY. Know when insiders buy.
One email the day a filing lands. Free.
HQY
HEALTHEQUITY, INC.
97.88
+1.28 +1.33%
USD · Oct 22, 04:20 a.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
30
FLAG · insiders 32, shorts 28
Insiders, 90 days
−$800K
net selling · 1 buy, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $8.1BP/E 35.3DIV YIELD —FCF YIELD 6.02%REV TTM $1.4B +7.3%NET INCOME $236.5M +62.2%NET DEBT $675.1M52W 73.21 – 106.79SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2027 · Jul 31 | $350.7M | +7.6% | 73.5% | $98.7M | $65.6M | +9.7% | 0.78 | $136.2M | $978K | $135.2M | Aug 27 |
| Q1 2027 · Apr 30 | $354.6M | +7.2% | 72.3% | $103M | $69.4M | +28.8% | 0.82 | $97.5M | $362K | $97.2M | May 28 |
| Q4 2026 · Jan 31derived | $334.6M | +7.3% | 68.2% | $71.1M | $49.7M | +88.7% | 0.58 | $117.9M | $326K | $117.6M | Mar 17 |
| Q3 2026 · Oct 31 | $322.2M | +7.2% | 70.8% | $78.7M | $51.7M | +806.4% | 0.59 | $138.6M | $784K | $137.8M | Dec 3 |
| Q2 2026 · Jul 31 | $325.8M | +8.6% | 71.4% | $89.6M | $59.9M | +67.1% | 0.68 | $135.9M | $773K | $135.1M | Aug 27 |
| Q1 2026 · Apr 30 | $330.8M | +15.0% | 67.8% | $83.1M | $53.9M | +87.1% | 0.61 | $64.7M | $86K | $64.7M | May 28 |
| Q4 2025 · Jan 31derived | $311.8M | +18.8% | 60.6% | $42.1M | $26.4M | +0.0% | 0.30 | $75.7M | $328K | $75.4M | Mar 17 |
| Q3 2025 · Oct 31 | $300.4M | +20.5% | 65.6% | $19.6M | $5.7M | −61.1% | 0.06 | $90.5M | $294K | $90.3M | Dec 3 |
| Q2 2025 · Jul 31 | $299.9M | — | 68.0% | $58.9M | $35.8M | — | 0.40 | $108.1M | $741K | $107.4M | Sep 2 |
| Q1 2025 · Apr 30 | $287.6M | — | 65.1% | $41.6M | $28.8M | — | 0.33 | $65.4M | $721K | $64.7M | Jun 3 |
| Q4 2024 · Jan 31 | $262.4M | — | 62.2% | $38.9M | $26.4M | — | 0.30 | $77.1M | $560K | $76.5M | Mar 17 |
| Q3 2024 · Oct 31 | $249.2M | — | 63.9% | $30.9M | $14.7M | — | 0.17 | $57.1M | $544K | $56.6M | Dec 9 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jan 31 | $1.3B | 69.5% | $322.5M | $215.2M | 16.4% | 2.46 | $457.1M | $2M | $455.1M | $299.3M | — |
| FY2025 · to Jan 31 | $1.2B | 64.8% | $162.3M | $96.7M | 8.1% | 1.09 | $339.9M | $2.1M | $337.8M | $121.5M | — |
| FY2024 · to Jan 31 | $1B | 62.3% | $117.7M | $55.7M | 5.6% | 0.64 | $242.8M | $1.7M | $241.1M | $0 | — |
| FY2023 · to Jan 31 | $861.7M | 57.1% | $9.1M | −$26.1M | -3.0% | -0.31 | $150.7M | $3.4M | $147.3M | $0 | — |
| FY2022 · to Jan 31 | $756.6M | 56.1% | −$24.2M | −$44.3M | -5.9% | -0.53 | $141M | $8.9M | $132.1M | — | — |
| FY2021 · to Jan 31 | $733.6M | 56.6% | $34M | $8.8M | 1.2% | 0.12 | $181.6M | $13.1M | $168.5M | — | — |
Every number comes from HEALTHEQUITY, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.